CLINICAL RESEARCH: INSULIN RESISTANCE, PLATELETS, AND OBESITY
Insulin Resistance as a Determinant of Platelet Activation in Obese Women
Stefania Basili, MD ,
Giovanni Pacini, DSC ,
Maria Teresa Guagnano, MD*,
Maria Rosaria Manigrasso, MD*,
Francesca Santilli, MD*,
Caterina Pettinella, BS*,
Giovanni Ciabattoni, MD*,
Carlo Patrono, MD and
Giovanni Davì, MD*,*
* Center of Excellence on Aging and Departments of Medicine and Drug Sciences, University of Chieti "G. DAnnunzio" Schools of Medicine and Pharmacy, Chieti, Italy
Metabolic Unit, Institute of Biomedical Engineering, National Research Council, Padova, Italy
Department of Medical Therapy, University of Rome "La Sapienza," Rome, Italy
Department of Pharmacology, University of Rome "La Sapienza," Rome, Italy
Manuscript received May 15, 2006;
revised manuscript received August 2, 2006,
accepted August 7, 2006.
* Reprint requests and correspondence: Dr. Giovanni Davì, Center of Excellence on Aging, "G. DAnnunzio" University Foundation, Via Colle dellAra, 66013 Chieti, Italy. (Email: gdavi{at}unich.it).
OBJECTIVES: We tested the hypothesis that insulin resistance, per se, contributes to increased platelet activation in obesity, independently of underlying inflammation.
BACKGROUND: Obesity, insulin resistance, and atherosclerosis are closely linked phenomena associated with low-grade inflammation. Obesity is associated with persistent platelet activation in otherwise healthy women.
METHODS: We performed a cross-sectional study in 40 obese and 20 non-obese healthy women using urinary thromboxane metabolite excretion as a non-invasive index of platelet activation. An index of insulin sensitivity, SI, and plasma adiponectin, C-reactive protein (CRP), and CD40 ligand (CD40L) levels were measured.
RESULTS: Obese women had significantly (p < 0.0001) higher 11-dehydro-thromboxane B2 (11-dehydro-TXB2) excretion (median 718 vs. 211 pg/mg creatinine), CRP (1.13 vs. 0.48 mg/l), and CD40L levels (4.45 vs. 0.90 ng/ml) than controls. Obese women had lower SI (median 2.51 vs. 5.0 104 min1/[µU/ml], p < 0.002) and adiponectin (6.3 vs. 10 µg/ml, p < 0.01) than control subjects. On multiple regression analysis, waist-to-hip ratio (ß = 0.27, p < 0.05) and SI (ß = 0.72, p < 0.04) predicted 11-dehydro-TXB2 excretion rate, independently of adiponectin, CRP, CD40L, and lipid patterns. In order to investigate the cause-effect relationship of these associations, we examined the effects of a 12-week weight loss program or a 3-week pioglitazone treatment on urinary 11-dehydro-TXB2 in 10 women with impaired SI and visceral obesity. Successful weight loss (0.6 kg loss/week) achieved in 5 subjects was associated with increased SI (+92%) and decreased CD40L (27%), CRP (37%), and 11-dehydro-TXB2 (53%) (p < 0.05). Consistently, improvement of insulin sensitivity achieved with pioglitazone significantly decreased urinary 11-dehydro-TXB2 excretion (43%, p < 0.05) without changes in body weight.
CONCLUSIONS: Insulin resistance is a major determinant of platelet activation in female obesity.
|
Abbreviations and Acronyms
| | 11-dehydro-TXB2
= 11-dehydro-thromboxane B2 | | AUC = area under the response curve | | BMI = body mass index | | CD40L = CD40 ligand | | CRP = C-reactive protein | | DI = disposition index | | FSIGT = insulin-modified frequently sampled intravenous glucose tolerance test | | OGIS = oral glucose insulin sensitivity | | OGTT = oral glucose tolerance test | | SI
= insulin sensitivity index | | WHR = waist-to-hip ratio | AIRG
= incremental acute insulin response |
|
This article has been cited by other articles:

|
 |

|
 |
 
C. Patel, H. Ghanim, S. Ravishankar, C. L. Sia, P. Viswanathan, P. Mohanty, and P. Dandona
Prolonged Reactive Oxygen Species Generation and Nuclear Factor-{kappa}B Activation after a High-Fat, High-Carbohydrate Meal in the Obese
J. Clin. Endocrinol. Metab.,
November 1, 2007;
92(11):
4476 - 4479.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|